Company Overview - Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products, including complex formulations [2] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and partners with global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories [2] Upcoming Investor Conferences - Lifecore management will participate in the Morgan Stanley 23 Annual Global Healthcare Conference from September 8-10, 2025, with a fireside chat scheduled for September 9, 2025, from 4:50 to 5:25 p.m. Eastern [3] - The company will also participate in the Barrington Research Virtual Fall Investment Conference on September 16, 2025, and the Jefferies CDMO Summit 2025 on September 17, 2025, in London, UK [3] Investor Engagement - A live webcast of the Morgan Stanley fireside chat will be accessible via Lifecore's investor website, with a replay available after the conference [1][3]